Company intelligence / Profile preview

BuddyRise

Ownership: Private
Development stage: Commercial

Overview

BuddyRise provides an AI-powered digital platform and mobile app that delivers personalized lifestyle guidance to individuals with autoimmune conditions. The solution integrates real-time wearable data and offers community support to help users manage their health holistically. There are no clinical trial results as the company does not develop therapeutics but focuses on digital/lifestyle interventions.

Therapeutic areas: Immunology
Modalities: Non-pharmacological therapyDigital health intervention
Industry: Digital Health Medical Devices

Partnerships

None listed in available sources; focus appears to be direct-to-consumer/community-based model

Beyond the preview

Go deeper on BuddyRise.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BuddyRise.

Explore the full profile